AOB American Oriental Bioengineering, Inc.

NEW YORK, May 5 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE:AOB), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products in China, today announced the Company's participation in the following conferences: -- Merrill Lynch Asian STARS 2009, held May 6-8 at the Ritz Carlton in Singapore. Ms. Lily Li, the Company's COO and CFO, is scheduled to meet with institutional investors and to participate in a panel discussion entitled "Asian Healthcare Sector - Immune to Economic Downturn?" -- Credit Suisse China Healthcare Tour, held the week of May 18th in China. -- Oppenheimer 3rd Annual China Dragon Call Conference, held May 19-21 at 300 Madison Avenue in New York City. Management is currently scheduled to meet with institutional investors and to present at 1:20 pm ET on Wednesday, May 20, 2009. For further details, please contact your respective sales representative. About American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc. is a China-based pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products. DATASOURCE: American Oriental Bioengineering, Inc. CONTACT: Integrated Corporate Relations, Inc., Ashley M. Ammon at +1-203-682-8208

Copyright